Dexcom and Ascensia Diabetes Care have struck a deal to provide the latter’s blood glucose meter as part of the former’s continuous glucose monitoring system for patients covered by Medicare. The ...
Stelo will be the first glucose biosensor in the US cleared for use without a prescription Indicated for use for people 18 years and older who are not using insulin therapy A small, wearable sensor ...
The FDA has officially cleared the Dexcom G5 continuous glucose monitor to inform treatment decisions -- without the use of a fingerstick glucometer, other than for calibration. The G5 has been ...
Dexcom G6 was the first Continuous Glucose Monitoring (CGM) System to be officially listed by the NIHB Drug Benefit program. BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), ...
Add Yahoo as a preferred source to see more of our stories on Google. Sugar can lead to high blood sugar and contributes to the development of diabetes. Monitoring blood sugar is a crucial part of ...
On the heels of the latest NICE guidelines, Dexcom ONE is in review by NHS England for addition to the Drug Tariff Dexcom ONE, a wearable sensor and transmitter, puts people firmly in control of their ...
Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more About one in three Americans, or 125 ...
Tech Times announced our 2015 CES Best of Innovation Honorees and the list of winners included everything from Samsung's ultra-thin and powerful Series 9 2015 Edition Ultrabook to LG's 4K Ultra HD TV ...
The U.S. Food and Drug Administration (USFDA) has, for the first time, approved an Over-The-Counter (OTC) glucometer to monitor blood sugar levels. The integrated Continuous Glucose Monitor (iCGM) can ...
During a trip to Kentucky with her middle school softball teammates, Jordan Miller endured a crisis most people living with Type 1 diabetes dread. Miller, now 19, had been excited about competing in a ...
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results